This glucagon-like peptide-1 (GLP-1) receptor agonist, through its multifaceted action, not only improves glycemic control but also facilitates weight reduction, thus addressing two critical components of metabolic syndrome
Weight stigma, bias, or discrimination based on body size can worsen eating disorders by lowering self-worth, deterring people from seeking care, and reinforcing restrictive or compensatory behaviors
Schmidt PT, Ljung T, Hartmann B, Hare KJ, Holst JJ, Hellstrm PM (2005) Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY
The 2026 Standards of Care by the American Diabetes Association (ADA) recommend them for adults with type 2 diabetes who also have obesity or overweight, atherosclerotic cardiovascular disease, heart failure, chronic kidney disease or metabolic-associated steatotic liver disease [4]
What happens if you dont drink enough water with Amoxicillin